Search

Search Constraints

You searched for: Author/Creator Fernandes Moça Trevisani, Virginia

Search Results

1. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies. (6th April 2022)

2. Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation. (November 2021)

3. OP0126 LYMPHOMA ARISING AT THE TIME OF DIAGNOSIS OF PRIMARY SJÖGREN SYNDROME: A HIGHLY-ACTIVE SYSTEMIC SUBSET OF THE DISEASE. (June 2019)

4. THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13, 051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY). (June 2019)

5. THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY). (June 2019)